Your browser is no longer supported. Please, upgrade your browser.
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-11.93 Insider Own2.70% Shs Outstand1.02B Perf Week-4.47%
Market Cap23.02B Forward P/E8.02 EPS next Y2.83 Insider Trans-0.04% Shs Float977.52M Perf Month1.84%
Income-12120.00M PEG- EPS next Q0.54 Inst Own69.60% Short Float3.36% Perf Quarter-5.97%
Sales19.75B P/S1.17 EPS this Y-27.20% Inst Trans1.21% Short Ratio2.67 Perf Half Y7.34%
Book/sh13.66 P/B1.66 EPS next Y-3.25% ROA-16.30% Target Price22.76 Perf Year92.94%
Cash/sh1.85 P/C12.28 EPS next 5Y-7.49% ROE-78.00% 52W Range11.49 - 25.96 Perf YTD19.63%
Dividend- P/FCF7.52 EPS past 5Y-57.50% ROI-36.00% 52W High-12.90% Beta0.83
Dividend %- Quick Ratio0.60 Sales past 5Y2.00% Gross Margin45.40% 52W Low96.78% ATR0.90
Employees51800 Current Ratio0.90 Sales Q/Q-19.40% Oper. Margin-59.00% RSI (14)50.53 Volatility3.33% 4.11%
OptionableYes Debt/Eq2.12 EPS Q/Q-151.50% Profit Margin-56.00% Rel Volume0.92 Prev Close22.67
ShortableYes LT Debt/Eq1.93 EarningsNov 01 BMO Payout- Avg Volume12.27M Price22.61
Recom3.00 SMA203.54% SMA502.52% SMA2006.57% Volume7,547,642 Change-0.26%
Nov-05-18Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-01-18Upgrade Leerink Partners Underperform → Mkt Perform
Sep-21-18Resumed Oppenheimer Perform
Sep-17-18Upgrade BTIG Research Sell → Neutral
Sep-07-18Downgrade Credit Suisse Outperform → Neutral
Jun-27-18Reiterated Citigroup Buy $25 → $27
Mar-20-18Resumed Jefferies Hold $19
Feb-12-18Upgrade Credit Suisse Neutral → Outperform
Feb-09-18Upgrade RBC Capital Mkts Underperform → Sector Perform
Feb-09-18Downgrade Piper Jaffray Neutral → Underweight
Feb-09-18Downgrade Gabelli & Co Buy → Hold
Feb-02-18Downgrade BTIG Research Neutral → Sell $17
Jan-26-18Reiterated Leerink Partners Underperform $15 → $17
Jan-25-18Reiterated Susquehanna Positive $22 → $24
Jan-18-18Downgrade BTIG Research Buy → Neutral
Jan-09-18Upgrade Mizuho Neutral → Buy $23
Jan-05-18Downgrade Wells Fargo Market Perform → Underperform
Jan-04-18Upgrade Citigroup Neutral → Buy
Jan-03-18Initiated Leerink Partners Underperform $15
Dec-15-17Upgrade Morgan Stanley Underweight → Equal-Weight
Nov-14-18 04:06PM  Migraine-Focused Biotech Has A Headache On Quarterly Losses Investor's Business Daily
07:46AM  Jim Cramer Weighs In On Dropbox, Teva And More Benzinga
Nov-13-18 06:46PM  Cramer's lightning round: Dropbox's stock is a buy even after the tech sell-off CNBC
Nov-12-18 09:29PM  4 Stocks Warren Buffett and Insiders Are Piling On Insider Monkey
Nov-08-18 08:32AM  Even Following the Latest Surge, Mylan Stock Has Plenty of Room to Grow InvestorPlace
Nov-07-18 09:40AM  Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes Zacks
09:30AM  Is Teva Pharmaceutical Industries (TEVA) Outperforming Other Medical Stocks This Year? Zacks
06:11AM  These 3 Value Stocks Are Absurdly Cheap Right Now Motley Fool
Nov-06-18 03:20PM  9 High-Risk Stocks to Buy for Massive Rewards InvestorPlace
Nov-05-18 01:56PM  These Health-Care Standouts Have More Room to Rise, Morgan Stanley Says
12:51PM  Teva To Deliver Cost Cuts, Earnings Surprise In Coming Years, Morgan Stanley Says In Upgrade Benzinga
10:00AM  Monday's Top Healthcare Stocks To Watch Ahead Of Elections ACCESSWIRE
Nov-02-18 09:53AM  Teva (TEVA) Q3 Earnings Beat, 2018 EPS View Up, Shares Rise Zacks
08:00AM  Todays Research Reports on Stocks to Watch: Teva Pharmaceutical and SELLAS Life Sciences ACCESSWIRE
Nov-01-18 08:30PM  [$$] Teva Passes Its Check-Up The Wall Street Journal +15.12%
04:35PM  Why Teva Pharmaceutical Industries Ltd. Stock Crushed It Today Motley Fool
04:32PM  Why Las Vegas Sands, DowDuPont, and Teva Pharmaceutical Industries Jumped Today Motley Fool
04:30PM  Israel's Teva gives upbeat outlook as restructuring proceeds Associated Press
04:10PM  Financial Results Spur 2 Stocks Higher on Thursday
04:00PM  Stocks rebound after October sell-off Yahoo Finance
12:04PM  [$$] Teva Passes Its Check-Up The Wall Street Journal
11:40AM  Stocks - Fitbit, Teva, DowDuPont Jump in Pre-market; Wayfair, Spotify Plunge
10:58AM  How Teva Beat the Big Pharma Curse to Win 2018
10:31AM  Eli Lilly (LLY) to Report Q3 Earnings: What's in the Cards? Zacks
09:58AM  [$$] Investors Buoyed by Teva's Turnaround Progress The Wall Street Journal
09:56AM  Stock Market News Daily Roundup November 1, Key Earnings Market Exclusive
09:40AM  Teva (TEVA) Beats on Q3 Earnings, Lags Sales, Shares Up Zacks
09:35AM  Teva Soars After Earnings Beat, Increased Guidance
07:51AM  Teva Pharm raises 2018 profit outlook after Q3 tops estimates Reuters
07:19AM  Teva stock surges 6% on Q3 beats, upbeat guidance MarketWatch
07:07AM  Teva Pharm Q3 profit tops estimates, raises 2018 profit forecast Reuters
07:00AM  Teva Reports Third Quarter 2018 Financial Results Business Wire
Oct-31-18 03:37PM  Teva Seeks to Break Its Streak of Post-Earnings Stock Losses Bloomberg
Oct-29-18 04:17PM  Knock Offs Loom For J&J's Blockbuster Why An Analyst Is Still Bullish Investor's Business Daily
10:02AM  Teva (TEVA) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-28-18 09:29AM  Economic Calendar - Top 5 Things to Watch This Week
Oct-26-18 01:42AM  Deckers Outdoor Corp (DECK) Q2 2019 Earnings Conference Call Transcript Motley Fool
Oct-22-18 10:42AM  Teva's move of N. American HQ from Montco to N.J. takes another step forward American City Business Journals
07:48AM  BRIEF-Harbin Pharmaceutical Signs Agreement With Israel's Teva Pharmaceutical Industries Reuters
Oct-21-18 08:23AM  Teva and New Jersey Governor Murphy Formalize North America Headquarters Move with Ceremony in Israel Business Wire
Oct-19-18 05:45PM  Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know Zacks
09:10AM  New Research: Key Drivers of Growth for Teva Pharmaceutical Industries, Axovant Sciences, SolarEdge Technologies, NantHealth, Kosmos Energy, and Retrophin Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Oct-17-18 01:59PM  Exclusive: Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva Reuters
01:38PM  Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva Reuters
11:25AM  Stocks - Netflix Soars in Pre-market; IBM, Tilray, Canopy Growth Sink; Tesla Rises
09:11AM  Regeneron's Dupixent Meets Goals in Nasal Polyps Studies Zacks
07:57AM  Stocks making the biggest move premarket: NFLX, IBM, CSX, UAL, TEVA & more CNBC
Oct-16-18 01:30PM  Stephanie Link's big buy in final trades CNBC Videos
Oct-12-18 10:32AM  U.S. appeals court upholds ruling that canceled Teva Copaxone patents Reuters
10:10AM  U.S. appeals court upholds ruling that canceled Teva Copaxone patents Reuters
Oct-11-18 10:55AM  Teva Gets FDA Committee Nod for Rituxan Biosimilar Filing Zacks
05:00AM  Teva Draws on Patient Experience to Empower Those Living with Chronic Conditions Business Wire
Oct-10-18 01:44PM  5 Warren Buffett Stocks That Might Not Be His Ideas Kiplinger
12:30PM  Celltrion and Teva Announce FDA Oncologic Drugs Advisory Committee Recommends Approval of Celltrion BLA for CT-P10, a Proposed Rituximab Biosimilar Business Wire
11:00AM  Teva Presents 25-year Safety Data from Longest Continuous Trial of COPAXONE® (glatiramer acetate injection) for the Treatment of Relapsing Forms of Multiple Sclerosis Business Wire
Oct-09-18 09:46AM  3 Headwinds Hindering Mylan Benzinga
Oct-08-18 07:00AM  Teva to Present New Data at 34th European Committee for Treatment and Research in Multiple Sclerosis Congress in Berlin Business Wire
Oct-05-18 07:00AM  Teva to Report Third Quarter 2018 Financial Results on November 1, 2018 Business Wire
Oct-04-18 06:46AM  [$$] France's Medincell Completes IPO The Wall Street Journal
Oct-02-18 10:10AM  Why Teva Pharmaceutical Industries Ltd. (TEVA) is Poised to Beat Earnings Estimates Again Zacks
Oct-01-18 02:01PM  Leerink: Improving Fundamentals Drive Teva Upgrade Benzinga
01:05PM  Teva Pharmaceutical Stock Wins 2 Upgrades: What You Need to Know Motley Fool
01:01PM  Teva Stock Is Struggling but 1 Analyst Says the Selloff Doesnt Make Sense
07:26AM  Teva's Worst Week of 2018 Prompts Goldman to Defend Stock Bloomberg
Sep-27-18 08:18PM  Eli Lilly Migraine Drug Approved and Will Be Free to Patients Bloomberg
03:00PM  Teva Announces Exclusive First-to-File Launch of a Generic Version of Cialis® in the United States Business Wire
02:31PM  U.S. judge dismisses Teva lawsuits against Lilly on migraine drug Reuters
Sep-26-18 04:34PM  Why Southwestern Energy, Teva Pharmaceutical Industries, and Chegg Slumped Today Motley Fool -5.63%
10:09AM  Opioid legislation could lift certain hospital operators, drugmakers MarketWatch
Sep-24-18 05:12PM  5 Asian Stocks Gurus Agree On
Sep-21-18 12:16PM  [$$] Lilly Approval to Spur Migraine-Prevention Market in Europe The Wall Street Journal
Sep-20-18 03:46PM  FDA chief: Looking to regulate nicotine in cigarettes Fox Business Videos
Sep-19-18 01:05AM  Teva Wins Approval From FDA for Blockbuster Migraine Drug InvestorPlace
Sep-18-18 02:33PM  Teva finds big tenant to take over lease at its OP headquarters American City Business Journals
09:30AM  Does Ajovy's Approval Make Teva a Pain-Free Stock to Buy? Motley Fool
08:00AM  Todays Research Reports on Stocks to Watch: Teva Pharmaceutical and TG Therapeutics ACCESSWIRE
07:00AM  Teva Announces Early Results of Debt Tender Offer and Election of Early Settlement Business Wire
Sep-17-18 07:53PM  [$$] Teva Investors Get Headache Relief The Wall Street Journal
05:01PM  Winners & Losers: September 17 Yahoo Finance Video
04:39PM  5 Top Stock Trades for Tuesday Trading Oracle, FedEx Earnings InvestorPlace
04:04PM  Stocks End Near Day's Lows on Expectations of New China Tariffs
03:13PM  Coca Cola shares climbing, Teva is soaring and Tesla takes a dive Yahoo Finance
03:07PM  Credit Suisse Lifts Teva Price Target, Says Execution Is Key For Migraine Drug Benzinga
02:25PM  Coca Cola, Teva and Tesla are the Yahoo Finance charts of the day. Yahoo Finance Video
01:56PM  Three big names in the blitz CNBC Videos
01:35PM  New Marijuana Stocks? & Earnings from ORCL and FDX | Free Lunch Zacks
12:29PM  [$$] Teva Investors Get Headache Relief The Wall Street Journal
10:55AM  Teva Shares Pop as FDA Approves Its Migraine Drug
10:50AM  Teva's (TEVA) Migraine Drug Ajovy Receives FDA Approval Zacks
09:39AM  Stocks Open Lower On Trade War Fears; This Chip Giant Upgraded Investor's Business Daily
09:30AM  Teva stock surges 7% after FDA approves migraine medication MarketWatch
09:29AM  Teva Soars, Tyson Slumps, Visa Slips
09:08AM  Teva's Preventive Migraine Treatment Approved By FDA Benzinga
08:00AM  Teva Analysts Say Migraine Drug Approval Gives Needed Relief Bloomberg
07:44AM  Stocks making the biggest move premarket: DWDP, AXP, BBBY, LULU, TSLA & more CNBC
Sep-15-18 04:39AM  Teva Migraine Drug Wins FDA Nod, Bolstering Turnaround Plan Bloomberg
Sep-14-18 10:00PM  ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults Business Wire
08:14PM  [$$] The Worst Is Over for Generic-Drug Stocks The Wall Street Journal
06:21PM  U.S. health regulator approves Teva's migraine drug Reuters
11:00AM  Acorda (ACOR) Stock Dips, FDA Delays Decision on Inbrija Zacks
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McClellan Michael JamesEVP, Chief Financial OfficerNov 05Sale22.733467,86511,644Nov 07 06:38 AM
O'Grady Brendan P.EVP, North America CommercialSep 18Sale23.711,24129,4201,388Sep 20 04:10 PM
Nazzi GianfrancoEVP, Growth Markets CommercialSep 18Sale23.691,37932,6707,005Sep 20 04:09 PM
Griffin Deborah AChief Accounting OfficerSep 18Sale23.712,37656,3280Sep 20 04:08 PM
Dethlefs SvenEVP Global Marketing&PortfolioSep 18Sale23.7162514,8177,265Sep 20 04:06 PM
Daniell RichardExec. VP, European CommercialSep 18Sale23.692,48858,9430Sep 20 04:04 PM
Daniell RichardExec. VP, European CommercialSep 10Sale21.2569614,7900Sep 11 04:17 PM
Codner Iris BeckEVP Global Brand&CommunicationAug 09Sale22.704,16594,5418,290Aug 13 08:34 AM
Dethlefs SvenEVP Global Marketing&PortfolioAug 03Buy21.922,00043,8406,445Aug 07 09:45 AM
MIGNONE ROBERTODirectorMay 10Buy19.32250,0004,829,7001,500,000May 11 04:15 PM
MIGNONE ROBERTODirectorMay 09Buy19.21500,0009,603,1501,250,000May 11 04:15 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 19Sale18.382,35843,3402,974Mar 20 04:16 PM
O'Grady Brendan P.EVP, North America CommercialMar 19Sale17.881,17921,0781,388Mar 20 04:13 PM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 19Sale17.894578,1775,746Mar 20 04:11 PM
McClellan Michael JamesEVP, Chief Financial OfficerMar 19Sale17.882875,13111,295Mar 20 04:10 PM
Griffin Deborah AChief Accounting OfficerMar 19Sale17.8894316,8590Mar 20 04:08 PM
Fridriksdottir HafrunExecutive VP, Global R&DMar 19Sale17.883486,2227,051Mar 20 04:07 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 19Sale17.8857110,2084,445Mar 20 04:06 PM
Daniell RichardExec. VP, European CommercialMar 19Sale17.891,29723,2060Mar 20 04:04 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 12Sale19.202,44146,8672,974Mar 14 04:35 PM
O'Grady Brendan P.EVP, North America CommercialMar 12Sale19.4973814,3831,388Mar 14 04:34 PM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 12Sale19.504618,9895,331Mar 14 04:31 PM
Griffin Deborah AChief Accounting OfficerMar 12Sale19.4995218,5540Mar 14 04:29 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 12Sale19.4957611,2263,837Mar 14 04:26 PM
Daniell RichardExec. VP, European CommercialMar 12Sale19.5071413,9220Mar 14 04:23 PM
O'Grady Brendan P.EVP, North America CommercialMar 05Sale19.3870513,6631,388Mar 06 04:20 PM
Griffin Deborah AChief Accounting OfficerMar 05Sale19.3877314,9810Mar 06 04:14 PM
Daniell RichardExec. VP, European CommercialMar 05Sale19.281,10821,3620Mar 06 04:08 PM
Sabag MarkEVP, Global Human ResourcesFeb 15Sale20.523,00061,56041,517Feb 20 08:31 AM
Sabag MarkEVP, Global Human ResourcesFeb 14Sale18.452,05037,82344,517Feb 20 08:31 AM